Searchable abstracts of presentations at key conferences in endocrinology

ea0082wa12 | Workshop A: Disorders of the hypothalamus and pituitary | SFEEU2022

Pituitary functions and Hypothalamic Pituitary Axis Assessment Post Pituitary Surgery

Naeem Ammara , Baldeweg Stephanie

47 year old gentleman referred to Neurosurgery Department with incidental findings of pituitary macroadenoma with chiasmal compression and cavernous sinus involvement, whilst getting investigated for tinnitus. His past medical history included chronic migraines only. He has been experiencing increased frequency of migraines along with lethargy, decreased libido and loss of morning erections for some time prior to presentation. His formal visual fields showed a slight inferior ...

ea0082wd13 | Workshop D: Disorders of the adrenal gland | SFEEU2022

Male infertility in CAH – a balance of risk?

Naeem Ammara , Srirangalingam Umasuthan

26 year old gentleman with classic salt-wasting CAH due to 21-hydroxylase deficiency was maintained on hydrocortisone 7.5mg+7.5mg+5mg along with fludrocortisone 100 mg OD. Due to inadequate biochemical control, his hydrocortisone was increased to 10mg+10mg+5mg initially, which was subsequently switched to prednisolone 5mg+2.5mg. His 17-OH progesterone continued to remain high (300-400 nmol/l) with suppressed gonadotrophins and a high normal testosterone suggestive of mostly ad...

ea0077p160 | Bone and Calcium | SFEBES2021

An interesting case of Turner syndrome and Parathyroid Carcinoma with recurrent mild asymptomatic hypercalcemia

Naeem Ammara , La Rosa Clementina

Introduction: Primary parathyroid carcinoma accounts for less than 1% of the parathyroid gland tumours and almost always presents as primary hyperparathyroidism. Very few Turner syndrome patients have been reported so far to present with primary hyperparathyroidism secondary to parathyroid adenoma. We report a case of parathyroid carcinoma in a 59 years old lady with Turner syndrome who is presenting with recurrent mild hypercalcemia.Case presentation: A...

ea0062p37 | Poster Presentations | EU2019

A unique case of Graves’ disease and Low Platelets

Naeem Ammara , Garg Anukul , Aung Htet Htet

Case history: A 38 years old Afro-Caribbean gentleman presented in June 2018 with symptoms of hyperthyroidism. He is a smoker and takes alcohol occasionally. Examination revealed fine tremors, tachycardia, moderate sized goitre with no thyroid bruit and right sided proptosis. Thyroid workup revealed suppressed TSH, raised free T4 and TRAb of 9.75 IU/L suggesting GravesÂ’ Thyrotoxicosis. He was started on 20 mg of Carbimazole (CBZ)OD with Propanolol. After initiating carbim...

ea0075p12 | Pituitary and neuroendocrinology | EYES2021

Apoplexy in a patient with a Plurihormone Pituitary adenoma with corticotroph predominance

Qamar Sulmaaz , Naeem Ammara , Baldeweg Stephanie

Introduction: Silent corticotroph adenomas(SCA) are defined as pituitary adenomas showing positive staining for adrenocorticotrophic hormone in immunohistochemical studies not associated with clinical/laboratory features of hypercortisolaemia. We report a case of SCA in a 61-year-old man, who presented with pituitary apoplexy.Case presentation: Patient presented with persistent diplopia of 3 months duration, associated with severe headache for 1 week. He...

ea0090p568 | Adrenal and Cardiovascular Endocrinology | ECE2023

Assessment of Practice around Corticosteroid Sick Day Rules in Transplant and Oncology Services of a Tertiary Hospital in UK

Naeem Ammara , Yousseif Ahmed , Khoo Bernard , Karra Efthimia , Armeni Eleni

Introduction: Long term treatment with corticosteroids has been widely used, due to the well documented immunosuppressive and anti-inflammatory activity. Corticosteroids are among the most widely prescribed drugs in oncology and post-transplant patients. However, long-term treatment with a dose of corticosteroids, which equals prednisolone 5mg/day for at least 4 weeks, is very likely to result in suppressed function of the hypothalamic pituitary adrenal (HPA) axis, a condition...

ea0063p1214 | Thyroid 3 | ECE2019

Graves’ disease and thrombocytopenia

Naeem Ammara , Aung Htet , Menon Ravi , Garg Anukul

Case History: 38 year old male presented with thyrotoxic symptoms and exophthalmos with an initial Free T4 of > 100 pmol/l; TSH < 0.01 mIU/l and thyroid receptor antibody positivity. He had a platelet count of 72* 109 /L at presentation and was started on carbimazole. A month later he had platelet count of 9* 109 /L with normal white cell count and haemoglobin levels. He was switched to propylthiouracil, but was readmitted with platelet count of 1...

ea0094p165 | Adrenal and Cardiovascular | SFEBES2023

Assess and improve (AAIM) implementation of corticosteroid sick day rules in transplant and oncology services. A single-centre steroid safety project

Naeem Ammara , Yousseif Ahmed , Khoo Bernard , Karra Efthimia , Armeni Eleni

Objective: The project was designed to Assess And IMprove (AAIM) the practice of healthcare professionals (HCPs) around the corticosteroid sick-day rule, involved in caring for transplant and oncology patients requiring treatment with corticosteroids long-term.Introduction: Corticosteroids are widely prescribed drugs in oncology and post-transplant patients. Long-term treatment with corticosteroids dose, which equals pre...

ea0082p32 | Poster Presentations | SFEEU2022

Pituitary Apoplexy presenting with acute hyponatraemia

Islam Quazi , Sahoo Saroj , Naeem Ammara , Eldigair Hiba , Mehta Jay , Khoo Bernard , Karra Efthimia , Yousseif Ahmed , Patel Dipesh , Armeni Elena

Case history: 48-years old man, with no comorbidities, presented to A&E due to global headache of 20 days duration, with associated intermittent vomiting, but no photophobia, cranial nerve impairment, neck pain or visual disturbance. The first head-scan (CT, computed tomography) was unremarkable, hence was discharged with safety advises. One week later, he represented to A&E with similar complaints. On enquiries, he mentioned to be reviewed by an optician 6 months ago,...

ea0086p249 | Neuroendocrinology and Pituitary | SFEBES2022

Acute hypoglycemia as the presenting manifestation secondary to pituitary metastasis in a patient with malignant melanoma

Sahoo Saroj , Eltayeb Randa , Islam Quazi , Naeem Ammara , Patel Dipesh , Yousseif Ahmed , Armeni Eleni , Karra Efthimia , Khoo Bernard , Grossman Ashley

Introduction: Pituitary metastasis (PM) is a rare condition and associated with a reduced life-span. The most common primary sites are breast and lung, followed by thyroid and renal cell carcinoma. Patients with PM are mostly asymptomatic and incidentally discovered during neuroimaging. Characteristic symptoms are reported in <20% and most commonly include visual involvement, diabetes insipidus, and panhypopituitarism. We here describe a case with malignant melanoma (MM) w...